FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891784789> ?p ?o ?g. }

• W2891784789 abstract "Abstract Background In advanced esophageal cancer, definitive combined chemoradiotherapy (d-CRT) is considered to be one of standard therapy in Japan. However, there have been few studies of the correlation of clinical factors and response to chemoradiotherapy. The aim of this study is to clarify the correlation of serum CRP level and response to definitive chemoradiotherapy for advanced esophageal cancer. Methods A total of 78 patients with clinical stage II/III esophageal cancer who were treated with d-CRT at our institute from 2002 to 2014 were retrospectively reviewed. 57 patients received chemotherapy using low-dose 5-FU and cisplatin, and remaining 19 patients received chemotherapy using standard-dose 5-FU and cisplatin according to the protocol described in the RTOG trial combined with radiation therapy. The patients were stratified by response to chemoradiotherapy by two groups. 60 patients (54 patients had a complete response and 6 had a partial response) were in Responder group, and 18 patients (7 patients had a stable disease and 11 had a progressive disease) were in Non- responder group. The correlation of survival rate and serum CRP level before d-CRT was evaluated. Results At the time of analysis, the median follow-up period was 32 months (range 3–124 months). The overall survival of the Responder group was significantly better than that of Non- responder group (P < 0.001). Univariate analysis showed that white blood cell > 8000/m3 (P = 0.036), CRP > 1.0mg/dl (P = 0.002), adventitia invasion (P = 0.04) and history of the smoking (P = 0.037) were predictive for response of d-CRT. Multivariate analyses identified serum CRP level (P = 0.002) as independent prognostic factors for response of d-CRT. Conclusion Our findings suggest that serum CRP level may be a useful marker to predict a response to definitive chemoradiotherapy. However, further examinations in the future will be necessary to determine its efficacy. Disclosure All authors have declared no conflicts of interest." @default.
• W2891784789 created "2018-09-27" @default.
• W2891784789 creator A5023988903 @default.
• W2891784789 creator A5024700700 @default.
• W2891784789 creator A5041287744 @default.
• W2891784789 creator A5068682593 @default.
• W2891784789 creator A5079880806 @default.
• W2891784789 creator A5081288010 @default.
• W2891784789 date "2018-09-01" @default.
• W2891784789 modified "2023-09-27" @default.
• W2891784789 title "PS02.039: SERUM CRP LEVEL IS A PROGNOSTIC FACTOR OF ESOPHAGEAL CANCER TREATED WITH DEFINITIVE CHEMORADIOTHERAPY" @default.
• W2891784789 doi "https://doi.org/10.1093/dote/doy089.ps02.039" @default.
• W2891784789 hasPublicationYear "2018" @default.
• W2891784789 type Work @default.
• W2891784789 sameAs 2891784789 @default.
• W2891784789 citedByCount "0" @default.
• W2891784789 crossrefType "journal-article" @default.
• W2891784789 hasAuthorship W2891784789A5023988903 @default.
• W2891784789 hasAuthorship W2891784789A5024700700 @default.
• W2891784789 hasAuthorship W2891784789A5041287744 @default.
• W2891784789 hasAuthorship W2891784789A5068682593 @default.
• W2891784789 hasAuthorship W2891784789A5079880806 @default.
• W2891784789 hasAuthorship W2891784789A5081288010 @default.
• W2891784789 hasConcept C121608353 @default.
• W2891784789 hasConcept C126322002 @default.
• W2891784789 hasConcept C143998085 @default.
• W2891784789 hasConcept C2778424827 @default.
• W2891784789 hasConcept C2779742542 @default.
• W2891784789 hasConcept C71924100 @default.
• W2891784789 hasConcept C90924648 @default.
• W2891784789 hasConceptScore W2891784789C121608353 @default.
• W2891784789 hasConceptScore W2891784789C126322002 @default.
• W2891784789 hasConceptScore W2891784789C143998085 @default.
• W2891784789 hasConceptScore W2891784789C2778424827 @default.
• W2891784789 hasConceptScore W2891784789C2779742542 @default.
• W2891784789 hasConceptScore W2891784789C71924100 @default.
• W2891784789 hasConceptScore W2891784789C90924648 @default.
• W2891784789 hasLocation W28917847891 @default.
• W2891784789 hasOpenAccess W2891784789 @default.
• W2891784789 hasPrimaryLocation W28917847891 @default.
• W2891784789 hasRelatedWork W1534453072 @default.
• W2891784789 hasRelatedWork W1828538861 @default.
• W2891784789 hasRelatedWork W1986809864 @default.
• W2891784789 hasRelatedWork W1995882620 @default.
• W2891784789 hasRelatedWork W1999591903 @default.
• W2891784789 hasRelatedWork W2013185969 @default.
• W2891784789 hasRelatedWork W2081238838 @default.
• W2891784789 hasRelatedWork W2153250077 @default.
• W2891784789 hasRelatedWork W2363482340 @default.
• W2891784789 hasRelatedWork W2394602890 @default.
• W2891784789 hasRelatedWork W2401338664 @default.
• W2891784789 hasRelatedWork W2403732016 @default.
• W2891784789 hasRelatedWork W2526367904 @default.
• W2891784789 hasRelatedWork W2589454944 @default.
• W2891784789 hasRelatedWork W2591296614 @default.
• W2891784789 hasRelatedWork W2734652857 @default.
• W2891784789 hasRelatedWork W2809920164 @default.
• W2891784789 hasRelatedWork W3106920628 @default.
• W2891784789 hasRelatedWork W3166162936 @default.
• W2891784789 hasRelatedWork W3185430590 @default.
• W2891784789 isParatext "false" @default.
• W2891784789 isRetracted "false" @default.
• W2891784789 magId "2891784789" @default.
• W2891784789 workType "article" @default.